Hosted on MSN31m
Shionogi’s Earnings Call: Growth Amidst Challenges
Shionogi & Co (($JP:4507)) has held its Q3 earnings call. Read on for the main highlights of the call. The recent earnings call for Shionogi & Co.
Daily9h
European Commission authorises ViiV Healthcare Vocabria plus Rekambys for HIV treatment in adolescents
London: GSK plc has announced that ViiV Healthcare, the global HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders, has announced that the European Commission has ...